PGLRX
Price
$17.65
Change
-$0.00 (-0.00%)
Updated
Jul 3 closing price
Net Assets
852.34M
VTISX
Price
$157.22
Change
+$0.31 (+0.20%)
Updated
Jul 3 closing price
Net Assets
492.72B
Interact to see
Advertisement

PGLRX vs VTISX

Header iconPGLRX vs VTISX Comparison
Open Charts PGLRX vs VTISXBanner chart's image
Putnam Focused International Equity R
Price$17.65
Change-$0.00 (-0.00%)
VolumeN/A
Net Assets852.34M
Vanguard Total Intl Stock Idx Instl Sel
Price$157.22
Change+$0.31 (+0.20%)
VolumeN/A
Net Assets492.72B
PGLRX vs VTISX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
PGLRX vs. VTISX commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PGLRX is a StrongBuy and VTISX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VTISX has more cash in the bank: 493B vs. PGLRX (852M). PGLRX (2.90) and VTISX (2.85) have matching dividends . PGLRX was incepted earlier than VTISX: PGLRX (22 years) vs VTISX (9 years). PGLRX (1.42) is less costly to investors than VTISX (0.05). PGLRX is a more actively managed with annual turnover of: 31.00 vs. VTISX (3.00). PGLRX has a lower initial minimum investment than VTISX: PGLRX (0) vs VTISX (3000000000). PGLRX annual gain was more profitable for investors over the last year : 20.10 vs. VTISX (14.56). VTISX return over 5 years is better than : 44.69 vs. PGLRX (17.54).
PGLRXVTISXPGLRX / VTISX
Total Expense Ratio1.420.053,021%
Annual Report Gross Expense Ratio1.420.053,021%
Fund Existence22 years9 years-
Gain YTD22.82518.109126%
Front LoadN/AN/A-
Min. Initial Investment03000000000-
Min. Initial Investment IRAN/AN/A-
Net Assets852M493B0%
Annual Yield % from dividends2.902.85102%
Returns for 1 year20.1014.56138%
Returns for 3 years51.2338.99131%
Returns for 5 years17.5444.6939%
Returns for 10 years46.15N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GDTC2.200.08
+3.61%
CytoMed Therapeutics Limited
ARQ5.860.10
+1.74%
Arq
ACEL12.120.09
+0.75%
Accel Entertainment
DNB9.10N/A
N/A
Dun & Bradstreet Holdings
STZ172.32-1.55
-0.89%
Constellation Brands